Abstract
A systematic review and meta‐analysis encompassing 15 clinical trials has concluded that pharmacogenomic‐guided depression treatment results in a small improvement in antidepressant efficacy relative to treatment as usual. There was no difference in treatment discontinuation rates between pharmacogenomic‐guided and conventional treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
